Figure 2

Baseline to one-year changes of the examined biomarkers’ levels by the study treatment (recanalization of infarct related artery (PCI) versus medical therapy alone (MED)). (A) - NT-proBNP- N-terminal prohormone of brain natriuretic peptide; (B) - VEGF-Vascular Endothelial Growth Factor; (C) - MMP-2-matrix metalloproteinase-2; (D) - MMP-9-matrix metalloproteinase-9; (E) - TIMP-2 - tissue inhibitor of matrix metalloproteinase-2; (F) - Galectin.